CSIMarket
 
Baird Medical Investment Holdings Limited  (NASDAQ: BDMD)
 

Baird Medical Investment Holdings Limited's Suppliers Performance

BDMD's Supply Chain




 
BDMD Costs vs Sales of Suppliers Growth

More on BDMD Suppliers






Baird Medical Investment Holdings Limited's Comment on Supply Chain


The company faces challenges related to raw material procurement and increased sales and distribution costs due to network expansion, which may affect gross profit margins. To commercialize its microwave medical devices in China, the company must obtain regulatory filings and registration certificates from the National Medical Products Administration (NMPA). These devices are categorized into Class I, II, and III, each subject to different levels of regulatory oversight. The approval process can be lengthy, costly, and unpredictable, potentially requiring clinical trials. Post-approval, any product modifications may necessitate additional regulatory review. Registration certificates are valid for five years and require renewal. As of February 6, 2023, the company has secured multiple registration certificates for various microwave ablation therapeutic apparatus and needles, including models MTI-5AT, MTI-5B, MTI-5C, MTI-5DT, MTI-5ET, and needle models XR-A2021W, XR-A2018W, XR-A2015W, XR-A2021R, XR-A2018R, XR-A1610W, and the J-20 series. The supplier Baird Medical is identified in regulatory filings.

Baird Medical Investment Holdings Limited's Comment on Supply Chain


The company faces challenges related to raw material procurement and increased sales and distribution costs due to network expansion, which may affect gross profit margins. To commercialize its microwave medical devices in China, the company must obtain regulatory filings and registration certificates from the National Medical Products Administration (NMPA). These devices are categorized into Class I, II, and III, each subject to different levels of regulatory oversight. The approval process can be lengthy, costly, and unpredictable, potentially requiring clinical trials. Post-approval, any product modifications may necessitate additional regulatory review. Registration certificates are valid for five years and require renewal. As of February 6, 2023, the company has secured multiple registration certificates for various microwave ablation therapeutic apparatus and needles, including models MTI-5AT, MTI-5B, MTI-5C, MTI-5DT, MTI-5ET, and needle models XR-A2021W, XR-A2018W, XR-A2015W, XR-A2021R, XR-A2018R, XR-A1610W, and the J-20 series. The supplier Baird Medical is identified in regulatory filings.







BDMD's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Baird Medical Investment Holdings Limited 31.13 21.88 -27.54 -
SUBTOTAL 0.00 0.00 0.00 -


Sources: Baird Medical Investment Holdings Limited's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Baird Medical Investment Holdings Limited’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.